Subjects with heart failure with preserved ejection fraction enrolled in the PhosphodiesteRasE-5 Inhibition to Improve CLinical Status And EXercise Capacity in Diastolic Heart Failure ( RELAX ) clinical trial ( n = 216 ) underwent baseline Doppler echocardiography , cardiopulmonary exercise testing , and cardiac MRI .